Hanmi Pharm. Stock Forecast for 2023 - 2025 - 2030
Updated on 04/24/2024
Hanmi Pharm. Stock Forecast and Price Target
Hanmi Pharm. has an average price target of ₩415000.00 recently offered by eleven notable experts for 2024, which would represent a potential upside of approximately 31.96% from the last closing price in April, 2024 if reached. This potential increase is based on a high estimate of ₩440000.00 and a low estimate of ₩327758.50. If you are interested in A128940 stock, you should also look at its competitors.
31.96% Upside
Hanmi Pharm. Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Hanmi Pharm.'s Price has decreased from ₩45.13k to ₩0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach ₩570.79k – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for Hanmi Pharm. will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩101.70k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩206.00k | Buy/Sell | ₩201.75k | 6.31% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩35.25k | Buy/Sell | ₩44.67k | 27.66% |
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
Hanmi Pharm. Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Revenue for Hanmi Pharm. has grown by 23.77%, going from ₩1.08T to ₩1.33T. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach ₩1.59T – an increase of 19.77%. In 2030, the professionals' prediction is that A128940's Revenue will decrease by 73.79%, reaching ₩349.00B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩112.30k | Buy/Sell | ₩156.10k | 38.02% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩103.10k | Buy/Sell | ₩124.29k | 45.49% |
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
.jpg)
Hanmi Pharm. Dividend per Share Forecast for 2023 - 2025 - 2030
Hanmi Pharm.'s Dividend per Share has grown in the last two years, jumping from ₩480.58 to ₩500.00 – an increase of 4.04%. In the next year, analysts predict that Dividend per Share will reach ₩503.89 – an increase of 0.78%. According to professionals, by 2030, Hanmi Pharm.'s Dividend per Share will have decreased by 1.68%, falling down to ₩491.58.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩29.65k | Buy/Sell | ₩40.62k | 41.65% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩11.11k | Buy/Sell | ₩13.50k | 44.01% |
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.37k | Buy/Sell | ₩20.00k | 46.61% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.15k | Buy/Sell | ₩38.00k | 37.74% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩68.80k | Buy/Sell | ₩74.50k | 18.46% |
Hanmi Pharm. EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Hanmi Pharm.'s EBITDA has grown, increasing from ₩110.32B to ₩250.74B – an increase of 127.29%. For next year, the 17 analysts predict EBITDA of ₩327.36B, which would mean an increase of 30.56%. Over the next seven years, the pros' prediction is EBITDAof ₩342.22B, which would mean a seven-year growth forecast of 36.49%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
Hanmi Pharm. EBIT Forecast for 2023 - 2025 - 2030
Hanmi Pharm.'s EBIT has increased by 214.23% In the last two years, going from ₩48.98B to ₩153.90B. In the next year, analysts expect EBIT to reach ₩235.84B – an increase of 53.24%. For the next seven years, the forecast is for EBIT to grow by 95.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.55k | Buy/Sell | ₩0.00 | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.13k | Buy/Sell | ₩17.66k | -100.00% |
Hanmi Pharm. EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Hanmi Pharm.'s EPS has decreased from ₩939.50 to ₩0.00 – a 100.00% drop. In the coming year, analysts are expecting an increase in EPS, predicting it will reach ₩11.88k – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for Hanmi Pharm. will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A053030 Stock Forecast | BINEX | - |
16
|
₩14.70k | Buy/Sell | ₩18.00k | -100.00% |
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩14.78k | Buy/Sell | ₩23.00k | 55.62% |
| A243070 Stock Forecast | Huons | Outperform |
18
|
₩34.30k | Buy/Sell | ₩45.00k | 57.43% |
.jpg)